Menu

Search

Nial Wheate

Nial Wheate

Senior Lecturer in Pharmaceutics, University of Sydney

Dr Wheate completed a Bachelor of Science degree with 1st class honours from the University of New South Wales whilst at the Australian Defence Force Academy. He then completed a PhD in medicinal chemistry under Professor J. Grant Collins. Since then he has worked in the School of Biomedical and Health Sciences at the University of Western Sydney (Australia) and the Strathclyde Institute of Pharmacy and Biomedical Science (Scotland) before taking up a position in the Faculty of Pharmacy at the University of Sydney (Australia) in 2012.

Dr Wheate's research interests lie in whole-of-pipeline discovery and development of platinum-based anticancer drugs including: design and synthesis, in vitro and in vivo screening, drug-DNA binding, nanoparticle based delivery, solid state chemistry and co-crystals, toxicology and pharmacokinetics, and dosage formulation. Additionally, his research also examines the drug delivery application of macrocycles (including cyclodextrins, cucurbiturils and pillararenes) and their host-guest complexes.

Dr Wheate was previously the Head of Cancer Research in the Faculty of Pharmacy.

Weekly Dose: methylprednisolone, a drug for treating inflammation but not rare kidney disease

Aug 03, 2017 16:37 pm UTC| Health

Methylprednisolone is a prescription drug used to treat conditions involving inflammation, like asthma, arthritis, gout, tendinitis, transplant rejection, allergic reactions, and the skin conditions eczema and...

Explainer: what is chemotherapy and how does it work?

Jun 01, 2017 14:12 pm UTC| Health

Chemotherapy is the use of drugs to treat cancer in humans and animals. It is rarely used in isolation and is often paired with surgery, radiotherapy and immunotherapy, or a combination of these. Chemotherapy works by...

New drugs on the PBS: what they do and why we need them

May 05, 2017 02:05 am UTC| Insights & Views Health

This week, the government announced the latest additions, amendments, and deletions from the Pharmaceutical Benefits Scheme (PBS): the program through which essential medicines are subsidised for Australian patients. The...

Fentanyl, the anaesthetic that may have been used as a chemical weapon on Chechen rebels

Jul 27, 2016 07:35 am UTC| Health

Fentanyl is a synthetic analgesic (pain relieving) drug in the same class as morphine. It is used to treat acute or chronic pain, including for epidurals given to women during childbirth. It is thought that in 2002...

1 

Economy

Trump Pushes China Market Access During High-Stakes Xi Summit

U.S. President Donald Trump announced Wednesday that his top priority during his state visit to China will be urging President Xi Jinping to open the Chinese market further to Western companies. Speaking aboard Air Force...

Asian Currencies Hold Steady as Strong U.S. Inflation Data Boosts Dollar

Asian currencies traded mostly flat on Wednesday after posting strong gains in the previous session, as higher-than-expected U.S. inflation data strengthened the U.S. dollar and pushed Treasury yields higher. Investors...

Asian Stocks Steady as Iran War Concerns Persist Ahead of Trump-Xi Summit

Asian stock markets traded in a narrow range on Wednesday as investors remained cautious over the ongoing Iran conflict and its potential impact on global inflation. Market sentiment also stayed focused on the upcoming...

Australia Housing Tax Reform Sparks Debate Over Property Investor Tax Breaks

Australian Prime Minister Anthony Albanese has triggered a major political and economic debate after announcing plans to scale back tax breaks for property investors, a move welcomed by many aspiring homebuyers but...

New Zealand Budget 2026 Focuses on Fiscal Discipline and Infrastructure Investment

New Zealand Prime Minister Christopher Luxon announced that the government will maintain strict control over day-to-day spending in Budget 2026 while significantly increasing capital investment to strengthen the countrys...

Politics

Trump Administration Appoints David Venturella as Acting ICE Director Amid Immigration Crackdown

The administration of U.S. President Donald Trump announced that Immigration and Customs Enforcement (ICE) official David Venturella will become the agencys new acting director following the departure of Todd Lyons at the...

Bahamas Election 2026: Prime Minister Philip Davis Secures Historic Second Term

Bahamian Prime Minister Philip Davis and the ruling Progressive Liberal Party (PLP) secured a decisive victory in the 2026 Bahamas general election, marking the first time in nearly three decades that a Bahamian leader has...

Tennessee Republicans Remove Democrats From Committees After Redistricting Protest

Tennessee House Speaker Cameron Sexton removed Democratic lawmakers from all committee and subcommittee assignments following protests over the states controversial congressional redistricting plan. The disciplinary action...

Russia Resumes Heavy Drone Attacks on Ukraine After Ceasefire Ends

Russian forces launched a new wave of attacks across Ukraines Dnipropetrovsk region on Tuesday, killing at least six people and injuring several others shortly after a temporary U.S.-mediated ceasefire expired. Ukrainian...

US-China Trade Talks Begin in South Korea Ahead of Trump-Xi Beijing Summit

U.S. Treasury Secretary Scott Bessent arrived in South Korea on Wednesday for high-level trade discussions with Chinese Vice Premier He Lifeng ahead of the much-anticipated summit between U.S. President Donald Trump and...

Science

Trump Administration Releases New UFO Files and Apollo Mission Records

The U.S. Defense Department has released dozens of previously classified UFO-related files following an order from President Donald Trump, sparking renewed debate over unidentified anomalous phenomena (UAP) and government...

China vs. NASA: The New Moon Race and What's at Stake by 2030

The space race is back and this time, its a direct competition between the United States and China for dominance on the lunar surface. NASAs Artemis II mission recently made history when four astronauts flew farther into...

NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey

NASAs Artemis II mission launched Wednesday, marking humanitys return to crewed lunar exploration for the first time since the Apollo era. Carrying four astronauts aboard the Orion spacecraft, this historic 10-day mission...

NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo

NASAs Artemis II mission launched Wednesday, marking humanitys return to crewed lunar exploration for the first time since the Apollo era. Carrying four astronauts aboard the Orion spacecraft, this historic 10-day mission...

NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission

The four astronauts chosen for NASAs Artemis II mission have touched down at Kennedy Space Center in Florida, marking the beginning of final launch preparations for the first crewed lunar journey in over 50 years. NASA...

Technology

Japan’s Top Banks to Gain Access to Anthropic’s Claude Mythos AI Model

Japans three largest banking institutions are expected to receive access to Claude Mythos, the advanced artificial intelligence model created by U.S.-based AI startup Anthropic, according to a report published by Nikkei on...

Samsung Shares Slide as Wage Talks Collapse, Raising Strike Fears

Samsung Electronics shares fell sharply on Wednesday after negotiations between the company and its largest labour union failed to produce a wage agreement, increasing concerns over a possible large-scale strike that could...

Arteris Stock Surges After Strong Q1 Earnings Beat and Higher 2026 Outlook

Arteris Inc. (NASDAQ: AIP) shares surged in after-hours trading on Tuesday after the semiconductor software company reported stronger-than-expected first-quarter 2026 earnings and raised its full-year revenue forecast. The...

Anthropic Eyes $300M Stainless Acquisition Amid Enterprise AI Expansion

Anthropic is reportedly in advanced discussions to acquire developer tools startup Stainless in a deal valued at more than $300 million, according to a report from The Information. The potential acquisition highlights the...

Nvidia CEO Jensen Huang to Join Trump’s China Visit Amid AI Chip Tensions

Nvidia CEO Jensen Huang is expected to join a group of top American business leaders accompanying U.S. President Donald Trump during his upcoming visit to China, according to two Reuters sources familiar with the matter....
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.